Doctor profile · Federal record
Dr. STEPHEN WERTH, M.D.
Dermatology Physician (CMS: DERMATOLOGY) · QUINCY, MA
- NPI 1093762734
- Accepts Medicare
- 41 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
300 CONGRESS ST, SUITE 408
QUINCY, MA 021690907
(617) 773-7431
fax (617) 773-9592
Credentials & registration
- NPI registered
- May 2006 — 20 yrs on file
- Profile last updated
- November 6, 2015
- Year of graduation
- 1985 — 41 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Massachusetts #73556
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1093762734. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
5,498
Distinct HCPCS
10
Medicare allowed
$469,289
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 1,798 | 1,521 | $99 | |
17003 |
Destruction of precancer skin growth, 2-14 growths | 1,408 | 327 | $8 | |
17000 |
Destruction of precancer skin growth, 1 growth | 603 | 530 | $64 | |
11102 |
Biopsy of related skin growth, first growth | 446 | 384 | $114 | |
11103 |
Biopsy of related skin growth, each additional growth | 259 | 121 | $58 | |
17110 |
Destruction of skin growth, 1-14 growths | 123 | 117 | $130 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 122 | 122 | $123 | |
12032 |
Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 101 | 92 | $336 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 101 | 86 | $140 | |
17262 |
Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 72 | 52 | $156 |
In context: peer comparison
Among 4 peers in this city , average services per provider: 150. This provider delivers 37× the peer median.Open Payments
Industry payments received
All-time total
$414
Transactions
16
Manufacturers
10
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 3 | $79.15 | |
| PFIZER INC. | 2 | $57.89 | |
| GENZYME CORPORATION | 1 | $49.08 | |
| Dermavant Sciences, Inc. | 2 | $43.50 | |
| Sandoz Inc. | 2 | $42.20 | |
| Arcutis Biotherapeutics, Inc. | 2 | $39.59 | |
| LEO Pharma Inc. | 1 | $30.00 | |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $25.71 | |
| Regeneron Healthcare Solutions, Inc. | 1 | $24.93 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $22.41 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,415
Patients
690
Total drug cost
$1,022,226
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Betamethasone Dipropionate | Generic | 175 | 80 | $8,799 |
| Fluorouracil | Generic | 159 | 141 | $12,304 |
| Betamethasone Diprop Augmented (Betamethasone/Propylene Glyc) | Brand | 153 | 89 | $10,384 |
| Ketoconazole | Generic | 138 | 70 | $2,575 |
| Triamcinolone Acetonide | Generic | 135 | 86 | $2,061 |
| Metronidazole | Generic | 99 | 48 | $6,171 |
| Methotrexate (Methotrexate Sodium) | Brand | 95 | 19 | $2,208 |
| Gabapentin | Generic | 93 | 23 | $1,162 |
| Hydroxychloroquine Sulfate | Generic | 60 | 0 | $2,116 |
| Doxycycline Hyclate | Generic | 57 | 25 | $1,421 |